Clinical Trials Logo

Clinical Trial Summary

Optical Coherence Tomography (OCT) image data will be evaluated for image quality and used to test post-processing algorithms to improve detection sensitivity for ophthalmic diseases.


Clinical Trial Description

Optical coherence tomography (OCT) is an established technology for ophthalmic diagnosis which can perform noncontact, noninvasive, real time, cross-sectional imaging of the retina and anterior eye. OCT has displaced ophthalmoscopy and stereo-photography as the gold-standard for clinical assessment and documentation of retinal microanatomy including thickness, cystoid structures, subretinal fluid and retinal traction. Despite these benefits, new technologies can still benefit patients including increasing the resolution, imaging speed, and contrast of OCT technologies. Since 2013, Dr. Tao's group has worked to develop and translate new ophthalmic imaging technologies. The goal of this proposal is to develop novel OCT technology for improved diagnostic sensitivity in ophthalmology. Specifically, the investigators will develop novel OCT imaging and image-processing methods to improve imaging speed and quality. Successful completion of this project will improve clinical diagnostics of ophthalmic diseases. Pre-clinical validation of system performance and ergonomics is a valuable step is clinical imaging technology development. The aim of this project is to performance system iterations on next-generation ophthalmic OCT imaging technologies over current-generation imaging systems on healthy adult volunteers prior to clinical translation. While system resolution, contrast, and speed can be (and will be) evaluated using calibration standards and phantoms, in vivo human imaging in healthy subjects is necessary to establish a baseline for system performance and image quality prior to clinical translation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05210478
Study type Observational
Source Vanderbilt University Medical Center
Contact Marybeth Carter, BS
Phone 615-936-1639
Email marybeth.l.carter@vumc.org
Status Not yet recruiting
Phase
Start date January 2025
Completion date January 2030

See also
  Status Clinical Trial Phase
Recruiting NCT01206127 - DSAEK- Postoperative Positioning and Transplant Dislocation N/A
Terminated NCT00764582 - Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery Phase 4
Recruiting NCT05870566 - Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision] N/A
Recruiting NCT02084745 - Timing of Glaucoma Drainage Device With Boston Keratoprosthesis N/A
Unknown status NCT00834782 - Comparison of DCT, ORA and GAT in Eyes After Penetrating Keratoplasty Phase 4
Withdrawn NCT00345020 - Deep Lamellar Endothelial Keratoplasty: Small Incision Technique
Completed NCT00000137 - Collaborative Corneal Transplantation Studies (CCTS) Phase 3
Recruiting NCT04339907 - Inflammatory Mediators of Glaucoma After Corneal Transplantation (AH-Tears) N/A
Active, not recruiting NCT00874835 - Corneal Endothelium Delivery Instrument Phase 2
Completed NCT00570648 - A Prospective Study of the Effect of Topical Sodium Hyaluronate Immediately Post-PKP on Time to Reepithelialization N/A
Enrolling by invitation NCT03461978 - Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures N/A
Completed NCT01694914 - Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium Phase 3
Completed NCT03381794 - The German Keratoplasty Registry of the German Ophthalmological Society (DOG) N/A
Recruiting NCT03105466 - Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea N/A
Completed NCT00409656 - Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients Phase 2
Recruiting NCT01018888 - Safety and Efficacy Study of Artificial Cornea Phase 4
Recruiting NCT04490902 - Clinical Study on the Treatment of Mixed Component Cornea for High Risk Keratoplasty N/A
Recruiting NCT04337944 - Endoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis (KPro-HP-Endo) N/A
Completed NCT01547975 - Retrospective Analysis of Surgical Outcomes After Corneal Transplantation N/A
Terminated NCT00447642 - Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty Phase 3